Cryo-Cell Shares Outstanding 2010-2025 | CCEL
Cryo-Cell shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Cryo-Cell Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 8 |
| 2023 | 8 |
| 2022 | 8 |
| 2021 | 8 |
| 2020 | 8 |
| 2019 | 8 |
| 2018 | 7 |
| 2017 | 8 |
| 2016 | 8 |
| 2015 | 10 |
| 2014 | 10 |
| 2013 | 11 |
| 2012 | 11 |
| 2011 | 12 |
| 2010 | 12 |
| 2009 | 12 |
| Cryo-Cell Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-02-28 | 8 |
| 2024-11-30 | 8 |
| 2024-08-31 | 8 |
| 2024-05-31 | 8 |
| 2024-02-29 | 8 |
| 2023-11-30 | 8 |
| 2023-08-31 | 8 |
| 2023-05-31 | 8 |
| 2023-02-28 | 8 |
| 2022-11-30 | 8 |
| 2022-08-31 | 8 |
| 2022-05-31 | 9 |
| 2022-02-28 | 9 |
| 2021-11-30 | 8 |
| 2021-08-31 | 9 |
| 2021-05-31 | 8 |
| 2021-02-28 | 8 |
| 2020-11-30 | 8 |
| 2020-08-31 | 8 |
| 2020-05-31 | 8 |
| 2020-02-29 | 8 |
| 2019-11-30 | 8 |
| 2019-08-31 | 8 |
| 2019-05-31 | 8 |
| 2019-02-28 | 8 |
| 2018-11-30 | 7 |
| 2018-08-31 | 8 |
| 2018-05-31 | 8 |
| 2018-02-28 | 7 |
| 2017-11-30 | 8 |
| 2017-08-31 | 8 |
| 2017-05-31 | 8 |
| 2017-02-28 | 7 |
| 2016-11-30 | 8 |
| 2016-08-31 | 8 |
| 2016-05-31 | 9 |
| 2016-02-29 | 9 |
| 2015-11-30 | 10 |
| 2015-08-31 | 10 |
| 2015-05-31 | 10 |
| 2015-02-28 | 10 |
| 2014-11-30 | 10 |
| 2014-08-31 | 10 |
| 2014-05-31 | 10 |
| 2014-02-28 | 11 |
| 2013-11-30 | 11 |
| 2013-08-31 | 11 |
| 2013-05-31 | 11 |
| 2013-02-28 | 11 |
| 2012-11-30 | 11 |
| 2012-08-31 | 11 |
| 2012-05-31 | 11 |
| 2012-02-29 | 11 |
| 2011-11-30 | 12 |
| 2011-08-31 | 12 |
| 2011-05-31 | 12 |
| 2011-02-28 | 12 |
| 2010-11-30 | 12 |
| 2010-08-31 | 12 |
| 2010-05-31 | 12 |
| 2010-02-28 | 12 |
| 2009-11-30 | 12 |
| 2009-08-31 | 12 |
| 2009-05-31 | 12 |
| 2009-02-28 | 12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.039B | $0.032B |
| CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect. | |||